Hoba Therapeutics ApS: Financial statements 2025
CVR: 38231170
Source: annual report 2025, Danish Business Authority
01/04/2024 – 31/03/2025
Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -38,348,438 and a net result of DKK -43,008,287 compared with DKK -27,806,718 the year before. Equity in the 2025 report amounted to DKK 26,061,902. The solvency ratio was 56.5%. The company had 8 employees in the financial year.
- Gross Profit
- DKK -38,348,438
- Profit/Loss
- DKK -43,008,287
- Equity
- DKK 26,061,902
- Total Assets
- DKK 46,100,229
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -38.3M | -43M | 26.1M | 8 |
| 2024 | - | -20.9M | -27.8M | 69.1M | 8 |
| 2023 | - | -9.4M | -13.9M | -32.9M | 6 |
| 2022 | 0 | -7.2M | -10.9M | -19M | 3 |
| 2021 | - | 1.4M | -1.9M | 8.2M | 3 |
Official annual report
How creditworthy is Hoba Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 19, 2025, Jean Marcel André Combalbert is registered as adm. dir. of Hoba Therapeutics ApS.
As of September 19, 2025, Torsten Meldgaard Madsen has stepped down as adm. dir. of Hoba Therapeutics ApS.
As of September 1, 2025, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 20%.
As of September 1, 2025, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 10%.
As of January 21, 2025, Kuang He has joined the board of directors of Hoba Therapeutics ApS.
As of January 21, 2025, Marie Allen Schroeder has left the board of directors of Hoba Therapeutics ApS.
About Hoba Therapeutics ApS
Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.
